<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829214</url>
  </required_header>
  <id_info>
    <org_study_id>OTO-313-201</org_study_id>
    <nct_id>NCT04829214</nct_id>
  </id_info>
  <brief_title>OTO-313 in Subjects With Unilateral Subjective Tinnitus</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Phase 2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Unilateral Subjective Tinnitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Otonomy, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Otonomy, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral&#xD;
      tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral&#xD;
      tinnitus.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, double-blind, placebo-controlled, multicenter</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Functional Index (TFI)</measure>
    <time_frame>Week 4, Week 8</time_frame>
    <description>The TFI is a validated, 25-item questionnaire; index score from 0 to 100; higher scores indicate a greater problem with tinnitus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily Tinnitus Loudness</measure>
    <time_frame>Start of Lead-in (2 weeks before Baseline) to end of study (Week 16)</time_frame>
    <description>Numerical rating scale from 0 (No Tinnitus) to 10 (Extremely Loud Tinnitus) collected every day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Tinnitus Annoyance</measure>
    <time_frame>Start of Lead-in (2 weeks before Baseline) to end of study (Week 16)</time_frame>
    <description>Numerical rating scale from 0 (Not Annoying) to 10 (Extremely Annoying) collected every day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>Week 4, Week 8, Week 12, Week 16</time_frame>
    <description>Change in overall tinnitus status as perceived by the subject</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Treatment Emergent Adverse Events</measure>
    <time_frame>Reported or observed during or after dosing (Baseline) up to end of study (16 Weeks)</time_frame>
    <description>An adverse event (AE) is any unfavorable and unintended diagnosis, symptom, sign, syndrome or disease which occurs during the study, having been absent at baseline, or, if present at baseline, appears to worsen. Treatment emergent means it started during or after dosing.</description>
  </other_outcome>
  <other_outcome>
    <measure>Audiometry</measure>
    <time_frame>Screening, after dosing (Baseline) up to end of study (16 Weeks)</time_frame>
    <description>Hearing function - clinically significant adverse change from Baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Otoscopic Examinations</measure>
    <time_frame>After dosing (Baseline) up to end of study (16 Weeks)</time_frame>
    <description>Ear examination - clinically significant adverse change from Baseline</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Subjective Tinnitus</condition>
  <arm_group>
    <arm_group_label>OTO-313</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OTO-313</intervention_name>
    <description>Single intratympanic injection</description>
    <arm_group_label>OTO-313</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Single intratympanic injection</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has early-onset subjective unilateral tinnitus that is persistent&#xD;
             (consistently aware of their tinnitus throughout much of the waking day).&#xD;
&#xD;
          -  Subject is able to use the diary to complete their daily tinnitus ratings.&#xD;
&#xD;
          -  Subject's tinnitus is likely of cochlear origin, e.g., associated with sensorineural&#xD;
             hearing loss; acute hearing loss from noise trauma, barotrauma, or traumatic cochlear&#xD;
             injury (acute acoustic trauma, blast trauma, middle ear surgery, inner ear&#xD;
             barotrauma); age related hearing loss; resolved otitis media; ototoxic drug exposure.&#xD;
&#xD;
          -  Subject is willing to comply with the protocol and attend all study visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has pulsatile tinnitus, temporomandibular joint disease (TMJ) associated with&#xD;
             tinnitus perception, tinnitus resulting from traumatic head or neck injury, or&#xD;
             tinnitus resulting from a tumor or stroke.&#xD;
&#xD;
          -  Subject is pregnant, lactating, or undergoing fertility treatment.&#xD;
&#xD;
          -  Subject has other clinically significant illness, medical condition or medical history&#xD;
             at Screening or Baseline that, in the Investigator's opinion, would likely reduce the&#xD;
             safety of study participation or compliance with study procedures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Study Manager</last_name>
    <email>otonomyclinicaltrials@otonomy.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Central California Clinical Research</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee Martinez</last_name>
      <phone>559-432-3303</phone>
      <phone_ext>206</phone_ext>
      <email>afrancis@ccent.com</email>
    </contact>
    <investigator>
      <last_name>Brent Lanier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Breathe Clear Institute</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shay Simes</last_name>
      <phone>310-750-3956</phone>
      <email>shay.s@breatheclearinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Steven E Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado, Department of Otolaryngology</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristi E Folchert</last_name>
      <phone>303-724-9528</phone>
      <email>kristi.englefolchert@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Cass, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado ENT &amp; Allergy</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80923</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Davis</last_name>
      <phone>719-867-7804</phone>
      <email>mdavis@coloradoent.com</email>
    </contact>
    <contact_backup>
      <phone>719-867-7800</phone>
    </contact_backup>
    <investigator>
      <last_name>Bryan M Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates of FL</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amal El Kalimi-Short</last_name>
      <phone>561-737-8584</phone>
      <email>amal@lightent.com</email>
    </contact>
    <investigator>
      <last_name>Joshua P Light, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates of Florida, LLC</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>O. Sandy DiBattista</last_name>
      <phone>561-939-0186</phone>
      <email>oadibattista@entaaf.com</email>
    </contact>
    <investigator>
      <last_name>Mark Widick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates of Florida, LLC</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Elliott</last_name>
      <phone>954-476-0400</phone>
      <email>jelliott@entaaf.com</email>
    </contact>
    <investigator>
      <last_name>Curtis D Johnson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates of Florida, LLC</name>
      <address>
        <city>Port Saint Lucie</city>
        <state>Florida</state>
        <zip>34952</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Robinson</last_name>
      <phone>772-398-9911</phone>
      <email>lrobinson@entaaf.com</email>
    </contact>
    <investigator>
      <last_name>John T Lanza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ear Research Foundation</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>941-556-4264</phone>
    </contact>
    <investigator>
      <last_name>Herbert Silverstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahendra Shah</last_name>
      <phone>312-942-9967</phone>
      <email>mahendrakumar_shah@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Elias Michaelides, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ChicagoENT</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60657</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ninos Joseph</last_name>
      <phone>773-289-1823</phone>
      <email>njoseph@chicagoent.com</email>
    </contact>
    <investigator>
      <last_name>Adam J Levy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentuckian Ear, Nose &amp; Throat</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Sheeley</last_name>
      <phone>502-894-8441</phone>
      <phone_ext>211</phone_ext>
      <email>ksheeley@kentuckianent.com</email>
    </contact>
    <investigator>
      <last_name>Sean Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced ENT and Allergy, PLLC</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rhonda Dase</last_name>
      <phone>502-893-0159</phone>
      <phone_ext>1184</phone_ext>
      <email>rdase@advancedentandallergy.com</email>
    </contact>
    <investigator>
      <last_name>Amy Ingram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tandem Clinical Research</name>
      <address>
        <city>Marrero</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Clinton</last_name>
      <phone>504-934-8424</phone>
      <email>Kclinton@tandemclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Adil Fatakia, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dent Neurosciences Research Center</name>
      <address>
        <city>Amherst</city>
        <state>New York</state>
        <zip>14226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Cox</last_name>
      <phone>716-250-7002</phone>
      <email>jcox@dentinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Lixin Zhang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charlotte Eye Ear Nose &amp; Throat Associates, P.A.</name>
      <address>
        <city>Matthews</city>
        <state>North Carolina</state>
        <zip>28105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jonathan Moss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Ear, Nose &amp; Throat Associates, PA</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Cleland</last_name>
      <phone>336-768-3361</phone>
      <email>JCleland@piedmontent.com</email>
    </contact>
    <investigator>
      <last_name>Kenneth S Maxwell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC Health Otolaryngology-Head and Neck Surgery</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Reinert</last_name>
      <phone>513-558-1719</phone>
      <email>gibsonrk@uc.edu</email>
    </contact>
    <investigator>
      <last_name>Ravi Samy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Ear, Nose &amp; Throat Clinic/CENTRI Inc.</name>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <zip>29118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Ansley</last_name>
      <phone>803-870-8770</phone>
      <email>sansley700@gmail.com</email>
    </contact>
    <investigator>
      <last_name>John F Ansley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spartanburg/Greer ENT &amp; Allergy</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe Carey</last_name>
      <phone>864-278-1429</phone>
      <email>jcarey@spartanburgent.com</email>
    </contact>
    <investigator>
      <last_name>Erik D. Steiniger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fort Worth ENT</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karyn Willyerd</last_name>
      <phone>682-718-1778</phone>
      <email>kwillyerd@berksonmedical.com</email>
    </contact>
    <investigator>
      <last_name>John McIntyre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT Associates of Texas</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75070</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moe Qureshi</last_name>
      <phone>214-619-0007</phone>
      <email>mqureshi@berksonmedical.com</email>
    </contact>
    <investigator>
      <last_name>Dale Ehmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alamo ENT Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>45227</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Gonzalez</last_name>
      <phone>210-545-0404</phone>
      <email>r.gonzalez@alamoent.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Rosenbloom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chrysalis Clinical Research</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rian Farr</last_name>
      <phone>435-656-1704</phone>
      <email>rfarr@sgccr.com</email>
    </contact>
    <investigator>
      <last_name>G. Paul Doxey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Virginia Medical School Department of Otolatyngology</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Addy Tham</last_name>
      <phone>757-388-6264</phone>
      <email>thama@evms.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Volsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Otolaryngology, P.C. DBA Richmond ENT</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Short</last_name>
      <phone>804-330-5501</phone>
      <email>gshort@richmondent.com</email>
    </contact>
    <investigator>
      <last_name>Michael Armstrong, Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HNO - Praxis Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Detlef Brehmer, MD</last_name>
      <phone>+49551498080</phone>
      <email>dr.d.brehmer@t-online.de</email>
    </contact>
    <investigator>
      <last_name>Detlef Brehmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HNO Praxis am Necker</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Horn, MD</last_name>
      <email>horns04@t-online.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Horn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HNO-Gemeinschaftspraxis</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Heimlich, MD</last_name>
      <phone>+496221314814</phone>
      <email>info@praxis-heimlich.de</email>
    </contact>
    <investigator>
      <last_name>Florian Heimlich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim Klinik für Otorhinolaryngologie, Kopf- und Halschirurgie</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Shell, MD</last_name>
      <phone>+49-621-383-5056</phone>
      <email>hnoci@umm.de</email>
    </contact>
    <investigator>
      <last_name>Angela Schell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne ZDROWA</name>
      <address>
        <city>Kraków</city>
        <zip>31-216</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Katarzyna Zajdel, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne PROMED</name>
      <address>
        <city>Kraków</city>
        <zip>31-411</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Grabowska</last_name>
      <phone>+48-690-334766</phone>
      <email>+monika.grabowska@cmpromed.pl</email>
    </contact>
    <investigator>
      <last_name>Piotr Łach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MT Medic Specjalistyczna Pralctyka Lekarska Tomasz Stapiński</name>
      <address>
        <city>Krosno</city>
        <zip>38-400</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tomasz Stapiński, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gloucestershire Hospitals NHS Foundation Trust</name>
      <address>
        <city>Gloucester</city>
        <zip>GL1 3NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Multi-Specialty Research Team</last_name>
      <phone>0300-422-5483</phone>
      <email>ghn-tr.generic.research@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Matthew Clark, MBBS, FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospitals NHS Trust</name>
      <address>
        <city>Norwich</city>
        <zip>NR47UY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Walker</last_name>
      <phone>01603-641449</phone>
      <email>carmen.walker@nnuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>John Phillips, MBBS/PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intratympanic injection</keyword>
  <keyword>IT injection</keyword>
  <keyword>gacyclidine</keyword>
  <keyword>tinnitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

